H.-F. Wang, Y.-Y. Zhang, H.-W. Zhuang, M. Xu

Department of Pediatric Surgery, Linyi Central Hospital, Linyi, China

The article “MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms’ tumor via targeting FRS2” by H.-F. Wang, Y.-Y. Zhang, H.-W. Zhuang, M. Xu, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3360-3369 – PMID: 28829507 has been retracted by the Editor in Chief.

Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/19E8759FF9D86F9AB839B4FCE08C62), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation.

The authors have been informed about the journal’s investigation but remained unresponsive and have not provided the study’s raw data.

The journal’s investigation identified numerous duplications within Figure 2, as well as duplications between Figure 2 and figures from previously published articles (https://doi.org/10.1111/cas.12656, https://doi.org/10.1016/j.biochi.2019.03.011). Duplications were also found within Figure 3 and between Figure 3 and previously published articles (doi: 10.12659/msm.921288, doi: 10.12659/msm.903462).

Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

H.-F. Wang, Y.-Y. Zhang, H.-W. Zhuang, M. Xu
Retraction Note: MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms’ tumor via targeting FRS2

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 20
Pages: 4402-4402
DOI: 10.26355/eurrev_202410_36857